Dow Down 0.09% Nasdaq Up 0.10%

Halozyme Therapeutics, Inc. (HALO)

-NasdaqGS
9.40 Down 0.03(0.32%) 10:49AM EDT - Nasdaq Real Time Price
Prev Close:9.43
Open:9.40
Bid:9.41 x 200
Ask:9.42 x 800
1y Target Est:14.50
Beta:1.99
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:9.28 - 9.47
52wk Range:6.88 - 18.18
Volume:183,667
Avg Vol (3m):1,511,390
Market Cap:1.16B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for HALO

Comparison

Symbol% ChgMkt Cap
HALODown 0.32%1.16B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):19.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.62
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes human enzymes. Its research focuses on human enzymes that transiently modify tissue under the skin to facilitate the delivery of injected drugs and ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback